Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Clobetasol propionate by AFYX Therapeutics for Vulvar Lichen Sclerosus: Likelihood of Approval
Clobetasol propionate is under clinical development by AFYX Therapeutics and currently in Phase II for Vulvar Lichen Sclerosus. According to...